Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance

Background An 8 amino acid peptide sequence derived from proliferating cell nuclear antigen (PCNA) has been shown to effectively kill several breast cancer and neuroblastoma cell lines when added exogenously to cell cultures.